Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06880679

Ultrasound Acute Chest Syndrome Sickle Cell Disease

Use of Point-of-Care Ultrasound (POCUS) for the Diagnosis of Acute Chest Syndrome in Patients With Sickle Cell Disease

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Indiana University · Academic / Other
Sex
All
Age
25 Years
Healthy volunteers
Not accepted

Summary

Feasibility and reliability of ultrasound in the inpatient hematology setting.

Detailed description

Acute chest syndrome (ACS) is a complication of sickle cell disease where individuals have symptoms of fever, low oxygen levels or difficulty breathing in the setting of a new lung finding on chest x-ray. Chest x-ray is a useful tool to identify it but has some side effects. The investigators think ultrasound will be an equally feasible, reliable tool and minimize some of the side effects associated with chest x-ray. Ultrasound is a non-invasive was to obtain an image that does not require radiation.

Conditions

Interventions

TypeNameDescription
DEVICEPoint of Care UltrasoundPoint of Care Ultrasound during hospitalization

Timeline

Start date
2025-04-08
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2025-03-18
Last updated
2026-04-09

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06880679. Inclusion in this directory is not an endorsement.